Phathom Pharmaceuticals Inc (NAS:PHAT)
$ 18.37 -0.57 (-3.01%) Market Cap: 1.25 Bil Enterprise Value: 1.19 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Phathom Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 21, 2020 / 01:45PM GMT
Release Date Price: $36.85 (-3.84%)
Terrie J. Curran
Phathom Pharmaceuticals, Inc. - President, CEO & Director

Good morning, and welcome to the 2020 Annual Shareholders' Meeting of Phantom Pharmaceuticals, Inc. I'm Terrie Curran, President and Chief Executive Officer of Phantom. It is my pleasure to welcome you here today for this, our first Annual Shareholders Meeting. I'd like to introduce the Chairman of Phantom, Dr. Tachi Yamada. Tachi?

Tadataka Yamada
Phathom Pharmaceuticals, Inc. - Independent Chairman

Thank you, Terrie, and welcome, everyone. Thank you for joining us today. We're excited to be hosting our virtual meeting with shareholders attending via by webcast. To help us conduct an orderly meeting, we ask that shareholders abide by the rules of conduct available through the link on the webcast screen. It is now shortly after 9:45 a.m. Eastern Time on May 21, and this meeting is officially called to order.

In light of the virtual meeting format, the polls are open now and shareholders can vote by clicking on the vote here button on the bottom of the webcast screen.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot